WallStreetZenWallStreetZen
Analyst Ranking
Top 30%
#1339 out of 4603 analysts
Average Return
+1.5%
Win Rate
45%32 out of 71
Risk vs Reward
Poor
Good

Peter Lawson's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Immunogen IncIMGN
+214.57%$5.01$15.76
2022-11-15 -
2023-11-14
Strong Buy
Immunogen IncIMGN
+187.55%$5.46$15.70
2022-09-09 -
2023-09-08
Strong Buy
Immunomedics IncIMMU
+171.17%$32.40$87.86
2020-05-05 -
2020-10-22
Strong Buy
Fate Therapeutics IncFATE
+170.37%$30.75$83.14
2020-03-04 -
2021-03-04
Strong Buy
Syndax Pharmaceuticals IncSNDX
+100.18%$11.28$22.58
2020-03-04 -
2021-03-04
Strong Buy

Peter Lawson's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Replimune Group IncREPL
3Strong Buy$17.00+103.23%Maintains
8 days ago
Biomea Fusion IncBMEA
2Hold$5.00-11.35%Downgrades
9 days ago
Tango Therapeutics IncTNGX
1Strong Buy$13.00+45.58%Maintains
23 days ago
Macrogenics IncMGNX
6Strong Buy$14.00+213.20%Maintains
a month ago
Relay Therapeutics IncRLAY
3Strong Buy$15.00+105.20%Upgrades
a month ago
Blueprint Medicines CorpBPMC
8Hold$75.00-28.94%Maintains
a month ago
Deciphera Pharmaceuticals IncDCPH
6Hold$26.00+1.60%Upgrades
2 months ago
Exelixis IncEXEL
4Hold$25.00+15.00%Downgrades
2 months ago
Tscan Therapeutics IncTCRX
1Strong Buy$9.00+7.14%Maintains
3 months ago
Arvinas IncARVN
5Strong Buy$60.00+133.74%Maintains
4 months ago
Iovance Biotherapeutics IncIOVA
4Strong Buy$22.00+169.61%Maintains
4 months ago
Springworks Therapeutics IncSWTX
3Strong Buy$63.00+63.42%Maintains
4 months ago
Fate Therapeutics IncFATE
3Strong Buy$10.00+177.01%Maintains
4 months ago
Immunogen IncIMGN
5Hold$31.00-0.74%Downgrades
6 months ago
Exscientia PLCEXAI
2Strong Buy$10.00+98.81%Maintains
8 months ago
Adaptimmune Therapeutics PLCADAP
2Strong Sell$1.00-0.99%Maintains
10 months ago
Prelude Therapeutics IncPRLD
4Hold$5.00+28.21%Maintains
10 months ago
Syndax Pharmaceuticals IncSNDX
2Strong Buy$34.00+69.07%Maintains
a year ago
Nurix Therapeutics IncNRIX
1Strong Buy$20.00N/AInitiates Coverage On
a year ago
Arcus Biosciences IncRCUS
4Strong Buy$35.00N/AMaintains
a year ago
Immunocore Holdings PLCIMCR
1Strong Buy$80.00N/AInitiates Coverage On
2 years ago
Neximmune IncNEXI
2Strong Buy$50.00N/AMaintains
2 years ago
Karyopharm Therapeutics IncKPTI
2Strong Buy$8.00N/AMaintains
2 years ago
Bicycle Therapeutics PLCBCYC
1Strong Buy$30.00N/AInitiates Coverage On
2 years ago
Cytomx Therapeutics IncCTMX
3Strong Buy$3.50N/AMaintains
2 years ago
Illumina IncILMN
1Strong Sell$365.00N/AMaintains
3 years ago
Agios Pharmaceuticals IncAGIO
2Strong Buy$46.00N/AUpgrades
4 years ago
Immunomedics IncIMMU
1Strong Buy$40.00N/AInitiates Coverage On
4 years ago
Epizyme IncEPZM
1Strong Buy$33.00N/AInitiates Coverage On
4 years ago
Xencor IncXNCR
1Strong Sell$28.00N/AInitiates Coverage On
4 years ago
Nektar TherapeuticsNKTR
1Strong Buy$30.00N/AInitiates Coverage On
4 years ago
Tesaro IncTSRO
1Hold$75.00N/ADowngrades
6 years ago
Celyad Oncology SaCYADY
1Strong Buy$49.00N/AInitiates Coverage On
6 years ago
Editas Medicine IncEDIT
1Strong Buy$45.00N/AUpgrades
6 years ago
Crispr Therapeutics AgCRSP
1Strong Buy$45.00N/AUpgrades
6 years ago
Juno Therapeutics IncJUNO
1HoldN/AN/ADowngrades
6 years ago
Affimed NvAFMD
1Strong Buy$70.00N/AInitiates Coverage On
7 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.